Side Effects Logo Master File
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Addiction and Drug Use

FDA Approves Slow-Release Painkiller

This product image provided by Purdue Pharma shows Hysingla, the first hard-to-abuse version of the painkiller hydrocodone. The Food and Drug Administration on Thursday, Nov. 20, 2014 approved Hysingla, a once-a-day tablet for patients with severe, round-the-clock pain that cannot be managed with other treatments. (Purdue Pharma via AP)
This product image provided by Purdue Pharma shows Hysingla, the first hard-to-abuse version of the painkiller hydrocodone. The Food and Drug Administration on Thursday, Nov. 20, 2014 approved Hysingla, a once-a-day tablet for patients with severe, round-the-clock pain that cannot be managed with other treatments. (Purdue Pharma via AP)

The FDA has approved a new opioid painkiller that releases over a 24-hour period, and is designed to reduce abuse by people chewing or smashing it into a powder for injection. However, the agency admits that abuse and overdose of the drug Hysingla is still possible.

Michael Regan of Bloomberg News spoke to Here & Now’s Jeremy Hobson about the new drug.

Guest

Copyright 2021 NPR. To see more, visit https://www.npr.org.